NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: DLLL 42.51%
US Companies Moving the Markets, Evening edition Fri, Feb 27, 2026 as of 4:00 pm ET
NASDAQ: BYND 32.83%
Expected US Company Earnings on Wednesday, February 25th, 2026
OTC: GHVNF 21.76%
Top 5 Canadian Mining Stocks This Week: Euro Manganese Gains 134 Percent
NASDAQ: ONMD 72.9%
OneMedNet Stock Soars 90% Following Real-World Data Platform Launch
NASDAQ: NGNE 21.95%
NASDAQ: ACXIF 21.95%
NASDAQ: DLLL 21.95%
NASDAQ: BYND 21.95%
NASDAQ: GHVNF 21.95%
